Eyes on next steps of orelabrutinib for MS
Eyes on the recovery and risk-reward
–2Q rev／np +1%／3%; all eyes on cost savings
1H24E preview： eyes on Android recovery and smart tech growth
Headwinds in 4Q24 in both China & export;Eyes on policy-driven recovery in 2025
How Nations Become Fragile: An AI-Augmented Bird’s-Eye View (with a Case Study of South Sudan)
China Technology–Global fabless／IDM 3Q23 wrap： PC／SP recovery, auto／ industrial mixed; Eye on Edge AI as new growth driver
2023 Investor Day： All eyes on profitability and smart EV business upside
Impairment as always; eyes on Aion’s upmarket
China Technology–Global fabless／IDM 2Q23 wrap： expect continued inventory correction for non-AI players; All eyes on NVDA 3Q23E guidance
公众号
小程序
社群
公众号小程序社群